RETRACTED: MiR-519b-3p Inhibits the Proliferation and Invasion in Colorectal Cancer via Modulating the uMtCK/Wnt Signaling Pathway
A Retraction of the Original Research Article
MiR-519b-3p inhibits the proliferation and invasion in colorectal cancer via modulating the uMtCK/Wnt signaling pathway
by Zhang Y, Sun M, Chen Y and Li B (2019). Front. Pharmacol. 10:741. doi: 10.3389/fphar.2019.00741
The journal retracts the 02 July 2019 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.
This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors agree with this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: MiR-519b-3p inhibits the proliferation and invasion in colorectal cancer via modulating the uMtCK/Wnt signaling pathway. Front. Pharmacol. 14:1285746. doi: 10.3389/fphar.2023.1285746
Received: 30 August 2023; Accepted: 30 August 2023;
Published: 06 September 2023.
Approved by:
Angelo A. Izzo, University of Naples Federico II, ItalyCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==